The Lancet Healthy Longevity

Discontinuation of statins for primary prevention of atherosclerotic cardiovascular disease in adults aged 75 years or older (SAGA/SITE): a multicentre, open-label, pragmatic, non-inferiority randomised trial

Randomised trial in 1,180 peopleInterventions

36 months, multicentre, registered NCT02547883

The paper

Fabrice Bonnet, Fabrice Bonnet, Pierre Poulizac, Show 307 more authorsStephane Zimmermann

Université de Bordeaux

The Lancet Healthy Longevity, 11 Aug 2026

doi.org/10.1016/j.lanhl.2026.100884PubMed 42580354